CYTOR and renal cell carcinoma: Overexpression of LINC00152 is reported to be associated with tumour progression and shorter survival in GC [10, 11], HCC [9], renal cell carcinoma [35], gallbladder cancer [30] and also with shorter overall and recurrence-free survival in CRC [16, 17].